InSysBio to take part in ESMO Congress 2021

events
Conference
July 28, 2021

July 28, 2021

InSysBio announces its participation in ESMO (European Sosiety For Medical Oncology) Virtual Congress 2021 which is held on September 16-21. InSysBio team’s abstract was accepted:

  • #3143 “Selection of the optimal dose for ALX148, a CD47 blocker, using pharmacokinetic/pharmacodynamic modeling” by Elena Vasileva1,2, Oleg Demin Jr2

Affiliation: 1 Lomonosov Moscow State University, Moscow, Russia; 2InSysBio, Moscow, Russia

Abstract is going to be published on September 13, 2021, 00:05 CEST (Central European Summer Time)

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

February 2020
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1. 19 Feb 2020 12:54 InSysBio to participate in ASCPT 2020 InSysBio announced its participation in 121st Annual meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT 2020) which is to be held on March 18-21, 2020 at Marriott Marquis Houston, TX. InSysBio welcomes visitors at the booth # 102. Oleg Demin, CEO of InSysBio, Tatiana Karelina, lead modeler in Alzheimer's Disease and Veronika Musatova, Head of IRT development team, will present the new version of IRT (Immune Response Template) and Cytocon DB (Cell and cYTOkine CONcentrations).
20
21
1. 21 Feb 2020 17:02 InSysBio presents an enhanced version of its Immune Response Template Database IRT Version 3.0.0 acquires a wide variety of updates and new options (Moscow – 21.02.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, moves forward to the future.
22
23
24
25
26
27
28
29
 
Upcoming Events
07.04
InSysBio to hold a workshop on Heta at QSPC 2026
08.04
InSysBio to participate in QSPC 2026
Tags
Latest News
28.01
InSysBio to announce a new collaborative project with BeOne Medicines
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling